Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Janux Therapeutics Inc JANX

Healthcare Biotechnology
Janux Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. It has developed two bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr... see more

Bullboard (NDAQ:JANX)

View:
Post by whytestockson Dec 04, 2024 4:15pm

Trading (JANX) With Integrated Risk Controls

Breaking News: $JANX Trading (JANX) With Integrated Risk Controls2024-12-04 15:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology ...more  
14
Post by IronFocus77on Dec 04, 2024 9:25am

$JANX Climbs, $MYNZ Gains Momentum

$JANX surges 48.8% to $59.86 on investor confidence in its cancer immunotherapy advancements. Similarly, $MYNZ’s rebound post-split positions it as a promising player in cancer diagnostics, offering a ...more  
24
Post by MikeTesteron Aug 02, 2024 12:17pm

Janux Therapeutics, Inc. (NASDAQ:JANX): A Promising Biopharm

https://beyondspx.com/2024/07/31/janux-therapeutics-inc-nasdaqjanx-a-promising-biopharmaceutical-company-developing-innovative-tumor-activated-immunotherapies/
45
Post by whytestockson Feb 27, 2024 2:45pm

Dow Dips Over 100 Points; J.M. Smucker Posts Upbeat Earnings

Just In: $JANX Dow Dips Over 100 Points; J.M. Smucker Posts Upbeat Earnings | BenzingaU.S. stocks traded mixed toward the end of trading, with the Dow Jones index falling more than 100 points on ...more  
42
Post by whytestockson Feb 27, 2024 10:45am

Norwegian Cruise Line Posts Strong Sales, Joins Hims & Hers

News; $JANX Norwegian Cruise Line Posts Strong Sales, Joins Hims & Hers Health, Sterling Infrastructure And Other Big Stocks Moving Higher On Tuesday | BenzingaU.S. stocks were mixed, with the Dow ...more  
36
Post by whytestockson Feb 27, 2024 10:00am

Biotech Headliners

News; $JANX Biotech Headliners2024-02-27 09:06:36 ET DENVER, Colo., Feb 27, 2024 ( 247marketnews.com )- The following companies are mentioned; Codexis (NASDAQ: CDXS ), Kraig Biocraft Laboratories ...more  
45